Abstract LB223: Discovery of INV-6452, a CDK2/4 inhibitor for the treatment of HR-positive HER2-negative breast cancer resistant to current CDK4/6 therapy

Authors: Chang Bai, Nansong Xia, Yexing Cao, Shujuan Huang, Danqi Chen, Hongjian Yang, Lishan Lin, Zhaopie Zeng, Jing Su, Yongkui Sun

Published: 2025-04-25

DOI: 10.1158/1538-7445.am2025-lb223

Source: Full article